These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 18161394)

  • 1. The Medicare Part D doughnut hole: effect on pharmacy utilization.
    Sun SX; Lee KY
    Manag Care Interface; 2007 Sep; 20(9):51-5, 59. PubMed ID: 18161394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the doughnut hole.
    Penna P
    Manag Care Interface; 2007 Sep; 20(9):49-50. PubMed ID: 18161393
    [No Abstract]   [Full Text] [Related]  

  • 3. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan.
    Nair KV; Frech-Tamas F; Jan S; Wolfe P; Allen RR; Saseen JJ
    J Health Care Finance; 2011; 38(2):38-53. PubMed ID: 22372031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US.
    Kim MH; Lin J; Kreilick C
    Adv Ther; 2009 Aug; 26(8):784-94. PubMed ID: 19690820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.
    Conwell LJ; Esposito D; Garavaglia S; Meadows ES; Colby M; Herrera V; Goldfarb S; Ball D; Marciniak M
    Am J Geriatr Pharmacother; 2011 Aug; 9(4):241-9. PubMed ID: 21616722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of drug consumption patterns for Medicare Part D patients.
    Pedan A; Lu J; Varasteh LT
    Am J Manag Care; 2009 May; 15(5):323-7. PubMed ID: 19435400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of Medicare Part D on prescription drug use by the elderly.
    Lichtenberg FR; Sun SX
    Health Aff (Millwood); 2007; 26(6):1735-44. PubMed ID: 17978393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in drug utilization for seniors without prior prescription drug insurance.
    Hudson N
    Find Brief; 2009 Mar; 12(2):1-3. PubMed ID: 19297802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Out-of-pocket pharmacy expenditures for veterans under medicare part D.
    Rupper RW; Bair BD; Sauer BC; Nebeker JR; Shinogle J; Samore M
    Med Care; 2007 Oct; 45(10 Supl 2):S77-80. PubMed ID: 17909387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.
    Cheng LI; Rascati KL
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1423-9. PubMed ID: 22508663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
    LaVange LM; Silverman HA
    Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closing the Medicare Doughnut Hole: Changes in Prescription Drug Utilization and Out-of-Pocket Spending Among Medicare Beneficiaries With Part D Coverage After the Affordable Care Act.
    Bonakdar Tehrani A; Cunningham PJ
    Med Care; 2017 Jan; 55(1):43-49. PubMed ID: 27547949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why using current medications to select a medicare Part D plan may lead to higher out-of-pocket payments.
    Domino ME; Stearns SC; Norton EC; Yeh WS
    Med Care Res Rev; 2008 Feb; 65(1):114-26. PubMed ID: 17942795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse selection in the Medicare prescription drug program.
    Riley GF; Levy JM; Montgomery MA
    Health Aff (Millwood); 2009; 28(6):1826-37. PubMed ID: 19887424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential impact of pharmacist interventions to reduce cost for Medicare Part D beneficiaries.
    Thatcher EE; Vanwert EM; Erickson SR
    J Pharm Pract; 2013 Jun; 26(3):248-52. PubMed ID: 23178417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How the doughnut hole affects prescription fulfillment decisions involving cardiovascular medications for Medicare Part D enrollees.
    Hales JW; George S
    Manag Care; 2010 Dec; 19(12):36-44. PubMed ID: 21291131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
    Sengupta S
    N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.